Beyond the Battlefield: Why Veterans Deserve Representation in Medical Research

Photo by Louis Reed on Unsplash

For many veterans, the fight does not end after discharge. The lingering effects of service, physical wounds, chronic conditions, and psychological challenges can follow them long after veterans fold their uniforms away. As military personnel transition into civilian life, they often become testaments to the resilience of the human spirit. But resilience alone cannot overcome systemic gaps, especially when it comes to representation in medical research.

Clinical trials shape the future of medicine. They inform the therapies, medications, and treatment protocols that millions rely on. However, if these trials fail to reflect the full diversity of the global population, the resulting treatments may fall short for specific demographics, including veterans.

Why Representation Matters in Clinical Trials

The importance of diverse participation in clinical trials cannot be overstated. Factors like age, ethnicity, socioeconomic status, and past trauma can influence how a person responds to treatment. Veterans bring a complex set of variables to the table, from combat-related injuries to long-term exposure to medications and stress. Their unique medical histories deserve to be factored into research data.

Despite this, clinical studies often underrepresent veterans. Trials frequently recruit participants from urban centers or academic hospitals, unintentionally excluding those living in rural areas, disabled populations, and individuals with limited healthcare access, all groups that include large veteran cohorts.

The result is a body of research that may not reflect the experiences or needs of those who have served.

Barriers to Participation

There are several reasons why clinical research leaves out veterans:

• Geographic limitations: Many veterans live far from major research institutions, limiting their access to in-person studies.
• Mistrust of institutions: Some veterans carry a deep skepticism of medical systems, particularly those who feel failed by the VA or previous providers.
• Administrative hurdles: Paperwork, eligibility requirements, and transportation costs can be barriers even for those willing to participate.

These factors combine to create an unspoken divide, one that limits research from capturing a truly complete picture of patient needs and outcomes.

Advancing Equity in Clinical Trials

To build a better future, clinical research must become more accessible and representative. A growing number of technology platforms are helping facilitate this shift. Tools now exist to conduct remote participation, integrate data across rural systems, and simplify the enrollment process. These solutions remove some of the friction that prevents people, especially veterans, from engaging in clinical trials.

Efforts to ensure equity in clinical trials are expanding. Decentralized and patient-focused trials are leading the way. By offering digital access, mobile applications, and simplified interfaces, researchers can reach participants in more meaningful and inclusive ways.

When we reduce gatekeeping in research and open the door to groups like veterans, we not only improve scientific accuracy but also uphold values of justice and dignity.

The Role of Veteran Advocacy

Veteran-focused organizations and advocacy groups can play a pivotal role in bridging this gap. By partnering with research institutions or biotech firms, they can help ensure that studies keep veteran needs in mind.

This might include:

• Developing consent forms that acknowledge service-related medical histories
• Incorporating trauma-informed care into trial protocols
• Hosting outreach efforts that build trust between veterans and research teams

Veterans are often described as warriors, leaders, and survivors. But they are also potential contributors to the next generation of medical breakthroughs—if given the chance.

Clinical Research as a Continuation of Service

Participating in a clinical trial can feel like a continuation of service for some veterans. It becomes a way to contribute to a mission greater than oneself to shape a better, more responsive healthcare system for fellow service members and future generations.

However, participation should not come at the cost of convenience or comfort. Equity-focused trial models respect the complexity of veterans’ lives. They understand that healing is not linear, mobility may be limited, and that earning trust takes time.

This is not about charity. It is about accountability. Veterans who offered their bodies and minds in defense of a nation deserve to be seen in the data that drives our medical future.

Evolve with Innovation

It is time for clinical research to evolve. Not only in how it innovates but in whom it includes. Veterans are not a fringe group; they are central to our nation’s health and history. If the next wave of medicine is to be truly transformative, it must be built on a foundation of inclusivity.

Elevating veteran participation in medical research is more than a scientific imperative. It is a moral one.